International Flavors & Fragrances Inc.

IFF Introduces AQUASCENT™: Advanced Water-Based Fragrance Technology

IFF introduced AQUASCENT™, a vegan, water-based carrier for fine fragrance made from biodegradable materials, under its Science of Performance platform. The technology supports fragrance loads of 10% to 25% — versus up to 15% for most comparable systems — while maintaining visual clarity, and can be shipped as a concentrate to reduce shipping weight and CO(2) emissions. IFF cites growing demand for water-based perfumes, with searches up 18% year-to-date and TikTok content generating over 15 million views; no financial impact was disclosed.

•25d ago

IFF Launches Omni-Bos™ PHY to Help Dairy Producers Get More Value from Feed

IFF launched Omni-Bos PHY, a novel phytase enzyme designed specifically for dairy cattle that unlocks nutrients already present in feed to improve efficiency, profitability and sustainability. The product rolls out first in the Middle East, Africa and Asia-Pacific; in one development study it decreased undegraded phytate in the abomasum by approximately 70% versus a control diet, with additional trials showing improved phosphorus digestibility and reduced nitrogen and phosphorus excretion. The launch gives IFF's Animal Nutrition & Health unit a differentiated entry into dairy nutrition amid ~2% projected annual growth in global milk production, though no revenue contribution or financial guidance was disclosed.

•1mo ago

IFF Report Finds GLP-1 Is Reshaping Food Choices and Eating Behaviors Among Indian Consumers

IFF released a new report titled 'Inside the India GLP-1 Consumer Journey,' which examines how the use of GLP-1 medications is altering food behaviors among consumers in major Indian cities like Delhi, Mumbai, and Bengaluru. The research indicates a shift toward smaller portion sizes and heightened label scrutiny, with 74% of users reading food labels more carefully and 90% reporting changes in taste perception. Despite changes in individual consumption habits, the report notes that household purchasing patterns for items like biscuits and sweets remain stable, suggesting a complex landscape for innovation in sensory satisfaction and hydration.

•2mo ago

IFF Reports Second Quarter 2026 Results; Announces Use of Proceeds Plan for Food Ingredients Divestiture

IFF reported Q2 continuing ops sales of $2.0 billion, up 2% year-over-year, with Adjusted Operating EBITDA of $408 million and margin expanding to 20.9%. The company agreed to sell its Food Ingredients business to CVC Capital Partners for $3.8 billion in net cash proceeds and authorized a $2.5 billion share repurchase program, including an immediate $500M accelerated repurchase in the second half of 2026. Full-year 2026 guidance for continuing operations estimates sales of $7.4 billion to $7.6 billion and Adjusted Operating EBITDA of $1.53 billion to $1.60 billion.

•2mo ago

IFF Declares Dividend for Third Quarter 2026

IFF's Board of Directors declared a regular quarterly cash dividend of $0.40 per share on the company's common stock. The dividend is payable on October 9, 2026 to shareholders of record as of September 18, 2026. This announcement maintains the status quo for the company's capital return policy heading into the third quarter.

•2mo ago

IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners.

IFF agreed to sell its portfolio of botanical extracts, vitamins & minerals, and food enhancement activities to SuanNutra, a portfolio company of Carbyne Equity Partners. The divested businesses generated approximately $170 million in revenue in 2025 and employ about 600 people across five manufacturing facilities. The transaction is expected to close by the end of 2026 and aligns with IFF's strategy to optimize its portfolio and focus on its core Taste, Scent, and Health & Biosciences businesses.

•3mo ago

IFF Launches SENSORA™, an Innovative Pro-Fragrance Technology Platform

IFF launched SENSORA, a patent-pending pro-fragrance technology platform that uses light activation to extend scent release in home, fabric, and personal care applications. The first application, Floral Fusion, is designed for liquid detergents to provide an evolving olfactive profile that can last up to 20 days. An internal IFF survey across 17 countries found that one-third of consumers expect laundry fragrances to last longer, driving the development of this sustained-release technology.

•3mo ago

IFF and ISIPCA Mark 10 Years of Joint Scent Design and Creation Master’s-Level Program

IFF celebrates the 10th anniversary of its IFF ISIPCA master's-level program for scent design, noting it has trained 180 professionals from 40 countries since 2016. The program reports a 100% job placement rate within six months of graduation, with alumni joining IFF and various FMCG organizations globally. Executives highlighted the initiative's success in building a pipeline of diverse talent that combines creative and scientific expertise to drive innovation.

•4mo ago

IFF: 8-K · asset sale

International Flavors & Fragrances (IFF) has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners for approximately $4.3 billion. The transaction values the business at an enterprise value-to-EBITDA multiple of approximately 10x, based on 2025 EBITDA of $430 million and sales of $3.1 billion. IFF will retain a ~10% minority equity interest in the spun-off business, valued at approximately $200 million, and expects to receive net cash proceeds of ~$3.8 billion. The company intends to use the proceeds for debt reduction, share repurchases, and reinvestment in its core Taste, Scent, and Health & Biosciences segments. The deal is expected to close by the end of Q2 2027, subject to regulatory approvals. While IFF expects near-term adjusted EPS dilution, it reiterates its full-year 2026 guidance of $10.5B-$10.8B in sales and $2.05B-$2.15B in adjusted operating EBITDA, signaling confidence in the remaining portfolio's performance.

SEC 8-K•4mo ago

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC

IFF has agreed to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion in enterprise value, marking a major step in its portfolio transformation strategy. The deal values the business at a 10x EBITDA multiple. IFF will retain a 10% minority stake worth roughly $200 million, allowing it to participate in future upside while receiving approximately $3.8 billion in net cash proceeds. The divestiture sharpens IFF’s focus on its higher-growth Taste, Scent, and Health & Biosciences segments. Management expects the transaction to be dilutive to adjusted EPS in the first 12 months but reiterated its full-year 2026 guidance, citing improved cash flow and balance sheet strength.

•4mo ago

IFF Reports First Quarter 2026 Results

IFF reported Q1 sales of $2.74 billion, a 4% decrease year-over-year but a 3% increase on a comparable currency-neutral basis driven by volume growth across all segments. Adjusted EPS excluding amortization was $1.25 with adjusted operating EBITDA of $568 million, up 8% on a comparable currency-neutral basis. Free cash flow totaled $92 million, an increase of $144 million year-over-year. The company reaffirmed its full-year 2026 guidance for sales of $10.5 billion to $10.8 billion and adjusted operating EBITDA of $2.05 billion to $2.15 billion.

•5mo ago